메뉴 건너뛰기




Volumn 18, Issue 5, 2010, Pages 533-537

Diclofenac in hyaluronic acid gel: An alternative treatment for actinic cheilitis

Author keywords

Actinic rays; Cheilitis; Diclofenac; Hyaluronic acid; Oral leukoplakia

Indexed keywords


EID: 78649416244     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/S1678-77572010000500018     Document Type: Article
Times cited : (21)

References (20)
  • 1
    • 34347360639 scopus 로고    scopus 로고
    • The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: A prospective study of 15 patients
    • Berking C, Herzinger T, Flaig MJ, Brenner M, Borelli C, Degitz K. The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients. Dermatol Surg. 2007;33:825-830.
    • (2007) Dermatol Surg , vol.33 , pp. 825-830
    • Berking, C.1    Herzinger, T.2    Flaig, M.J.3    Brenner, M.4    Borelli, C.5    Degitz, K.6
  • 2
    • 0035964468 scopus 로고    scopus 로고
    • An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs
    • Brown MB, Hanpanitcharoen M, Martin GP. An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. Int J Pharm. 2001;225:113-121.
    • (2001) Int J Pharm , vol.225 , pp. 113-121
    • Brown, M.B.1    Hanpanitcharoen, M.2    Martin, G.P.3
  • 3
    • 34247333077 scopus 로고    scopus 로고
    • The role of apoptosis in the therapy and prophylaxis of epithelia tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
    • Fecker LF, Stockfleth E, Nindl I, Ulrich C, Forschner T, Eberle J. The role of apoptosis in the therapy and prophylaxis of epithelia tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol. 2007;156(Suppl 3):25-33.
    • (2007) Br J Dermatol , vol.156 , Issue.SUPPL. 3 , pp. 25-33
    • Fecker, L.F.1    Stockfleth, E.2    Nindl, I.3    Ulrich, C.4    Forschner, T.5    Eberle, J.6
  • 4
    • 0037325491 scopus 로고    scopus 로고
    • Topical diclofenac in hyaluronan gel for the treatment of solar keratoses
    • Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol. 2003;44:40-43.
    • (2003) Australas J Dermatol , vol.44 , pp. 40-43
    • Gebauer, K.1    Brown, P.2    Varigos, G.3
  • 5
    • 33748665256 scopus 로고    scopus 로고
    • Terezhalmy GT The patient with actinic cheilitis
    • Huber MA, Terezhalmy GT The patient with actinic cheilitis. Gen Dent. 2006;54:274-282.
    • (2006) Gen Dent , vol.54 , pp. 274-282
    • Huber, M.A.1
  • 7
    • 3042791868 scopus 로고    scopus 로고
    • Actinic cheilitis: Clinical and pathologic characteristics in 65 cases
    • Markopoulos A, Albanidou-Farmaki E, Kayavis I. Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Ora Dis. 2004;10:212-216.
    • (2004) Ora Dis , vol.10 , pp. 212-216
    • Markopoulos, A.1    Albanidou-Farmaki, E.2    Kayavis, I.3
  • 9
    • 0029617370 scopus 로고
    • Hyaluronan as a drug delivery system for diclofenac: A hypothesis for mode of action
    • Moore AR, Willoughby DA. Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React. 1995;17:153-156.
    • (1995) Int J Tissue React , vol.17 , pp. 153-156
    • Moore, A.R.1    Willoughby, D.A.2
  • 10
    • 34548863927 scopus 로고    scopus 로고
    • A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip
    • Nelson CG, Spencer J, Nelson CG Jr. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip. J Drugs Dermatol. 2007;6:712-717.
    • (2007) J Drugs Dermatol , vol.6 , pp. 712-717
    • Nelson, C.G.1    Spencer, J.2    Nelson Jr., C.G.3
  • 12
    • 27744588722 scopus 로고    scopus 로고
    • Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: A meta-analysis of the recent studies
    • Pirard D, Vereecken, Mélot C, Heenen M. Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res. 2005;297:185-189.
    • (2005) Arch Dermatol Res , vol.297 , pp. 185-189
    • Pirard, D.1    Vereecken, M.C.2    Heenen, M.3
  • 13
    • 0036178561 scopus 로고    scopus 로고
    • Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel
    • Rivers JK, Arlette J, Shear N, Guenther L, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel. Br J Dermatol. 2002;146:94-100.
    • (2002) Br J Dermatol , vol.146 , pp. 94-100
    • Rivers, J.K.1    Arlette, J.2    Shear, N.3    Guenther, L.4    Carey, W.5    Poulin, Y.6
  • 14
    • 0030841385 scopus 로고    scopus 로고
    • An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses
    • Rivers JK, McLean DI. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses. Arch Dermatol. 1997;133:1239-1242.
    • (1997) Arch Dermatol , vol.133 , pp. 1239-1242
    • Rivers, J.K.1    McLean, D.I.2
  • 15
    • 0024470716 scopus 로고
    • Actinic cheilitis. A prospective study comparing four treatment methods
    • Robinson JK. Actinic cheilitis. A prospective study comparing four treatment methods. Arch Otolaryngol Head Neck Surg. 1989;115:848-852.
    • (1989) Arch Otolaryngol Head Neck Surg , vol.115 , pp. 848-852
    • Robinson, J.K.1
  • 17
    • 33646204466 scopus 로고    scopus 로고
    • Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp
    • Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156-159.
    • (2006) J Drugs Dermatol , vol.5 , pp. 156-159
    • Smith, S.R.1    Morhenn, V.B.2    Piacquadio, D.J.3
  • 18
    • 34247352114 scopus 로고    scopus 로고
    • Management of actinic cheilitis using diclofenac 3% gel: A report of six cases
    • Ulrich C, Forschner T, Ulrich M, Stockfleth E, Sterry W, Termeer C. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases. Br J Dermatol. 2007;156(Suppl 3):43- 46.
    • (2007) Br J Dermatol , vol.156 , Issue.3 SUPPL. , pp. 43-46
    • Ulrich, C.1    Forschner, T.2    Ulrich, M.3    Stockfleth, E.4    Sterry, W.5    Termeer, C.6
  • 19
    • 0035659622 scopus 로고    scopus 로고
    • Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses
    • Wolf JE Jr, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40:709-713.
    • (2001) Int J Dermatol , vol.40 , pp. 709-713
    • Wolf Jr., J.E.1    Taylor, J.R.2    Tschen, E.3    Kang, S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.